Perturbed membrane-binding compounds

Details for Australian Patent Application No. 2002218431 (hide)

Owner NST NeuroSurvival Technologies Ltd.

Inventors Shirvan, Anat; Ziv, Ilan; Ebner, Sharon

Agent Griffith Hack

Pub. Number AU-B-2002218431

PCT Pub. Number WO02/46147

Priority 140114 06.12.00 IL; 145210 30.08.01 IL; 141571 21.02.01 IL

Filing date 3 December 2001

Wipo publication date 18 June 2002

Acceptance publication date 17 April 2008

International Classifications

C12Q 1/02 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving viable micro-organisms

A61K 31/18 (2006.01) - Sulfonamides

A61K 31/192 (2006.01)

A61K 31/194 (2006.01)

A61K 31/195 (2006.01)

A61K 31/198 (2006.01)

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61K 49/00 (2006.01) Preparations for testing

A61K 49/04 (2006.01) Preparations for testing - X-ray contrast preparations

A61K 51/00 (2006.01) Preparations containing radioactive substances for use in therapy or testing

A61M 1/34 (2006.01) Suction or pumping devices for medical purposes - Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration, diafiltration

A61P 1/00 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 1/04 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 5/14 (2006.01) Drugs for disorders of the endocrine system

A61P 7/02 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 7/06 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 17/00 (2006.01) Drugs for dermatological disorders

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 21/04 (2006.01) Drugs for disorders of the muscular or neuromuscular system

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/14 (2006.01) Drugs for disorders of the nervous system

A61P 25/16 (2006.01) Drugs for disorders of the nervous system

Event Publications

17 April 2008 Application Accepted

  Published as AU-B-2002218431

14 August 2008 Standard Patent Sealed

22 October 2009 Amendment Made

  The nature of the amendment is: Amend the Patentee name from NST NeuroSurvival Technologies Ltd to Aposense Ltd.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002218432-AN IMPROVED WEFT SUPPLIER, PARTICULARLY FOR FLUID-JET LOOMS

2002218430-Method and apparatus for the measurement of intra-abdominal pressure